DrugPatentWatch Database Preview
Profile for Canada Patent: 2580136
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Canada Patent: 2580136
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Jun 3, 2028 | Acadia Pharms Inc | NUPLAZID | pimavanserin tartrate |
Start Trial | Sep 26, 2025 | Acadia Pharms Inc | NUPLAZID | pimavanserin tartrate |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |